or 

Product


Pain Management

  • Recofol
  • Sufentanil
  • Ruituoxi
  • AF102

    • Gastroenterology

  • Lactéol Fort
  • Oral Rehydration Salts

    • Nephrology

  • Phosmin
  • FC818
  • Luolinping
  • Calcitriol
  • M8
  • NKF201
  • NKF202

    • Oncology

  • 801
  • AD1

    • Consumer Health

  • Xiexinshu SR
  • High-C
  • C+

    • Product

    PUMC Pharmaceutical’s drug development and marketing activities focus on the following core therapeutic areas:

      Preclinical Phase I Phase II Phase III Registration
    Pending    		 Marketed

    Pain Management

    		           
    Recofol®
    Sufentanil
    Ruituoxi®  
    AF102  
                 

    Gastroenterology

    		            
    Lactéol Fort®
    Oral Rehydration Salts  
                 

    Nephrology

    		            
    Phosmin          
    FC818    
    Luolinping®  
    Calcitriol    
    M8  
    NKF201  
    NKF202  
                 

    Oncology

    		            
    AD1          
    801          
                 

    Consumer Health

    		           
    C+
    High-C
    Xiexinshu®

     
        PUMC Pharmaceutical Co., Ltd.  
      © 2011 PUMC Pharmaceutical Co., Ltd. All Rights Reserved.
    冀ICP备09033487号-1 Terms of Use.